← back to search

Sylwia Szymczak

Eli Lilly (United States) · US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
h-index
3
citations
623
works
5
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial
The Lancet Oncology 2022cited by 411position: middledoi
Selpercatinib in Patients With <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
Journal of Clinical Oncology 2022cited by 199position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Vivek Subbiah · International Drug Development2 papers (2022–2022)Alexander Drilon · Université Grenoble Alpes2 papers (2022–2022)Jürgen Wolf · Université Grenoble Alpes2 papers (2022–2022)Victoria Soldatenkova · Eli Lilly (Singapore)2 papers (2022–2022)Guzmán Alonso · California State University System1 papers (2022–2022)Keunchil Park · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Herbert H. Loong · Shanghai Chest Hospital1 papers (2022–2022)Bhavana Konda · U-M Rogel Cancer Center1 papers (2022–2022)Kōichi Goto · Université Grenoble Alpes1 papers (2022–2022)Loretta Sullivan · Astellas Pharma (United States)1 papers (2022–2022)Scott Barker · Royal Veterinary College1 papers (2022–2022)Alexander I. Spira · Inova Fairfax Hospital1 papers (2022–2022)Benjamin Solomon · Peter MacCallum Cancer Centre1 papers (2022–2022)Pascale Tomasini · Centre de Recherche en Cancérologie de Marseille1 papers (2022–2022)Daniel S.W. Tan · National Cancer Centre Singapore1 papers (2022–2022)Oliver Gautschi · University of Bern1 papers (2022–2022)Hyunseok Kang · Kangbuk Samsung Hospital1 papers (2022–2022)Masayuki Takeda · University of Yamanashi1 papers (2022–2022)Jennifer Wright · Eli Lilly (United States)1 papers (2022–2022)Yuichiro Ohe · National Cancer Research Institute1 papers (2022–2022)